Physicians’ Equity in Company Marketing Cosmetic Drug Faces Ethical Questions
Published in InsideSources
Bioethics and Humanities Feb 10, 2020
Ethical questions are being raised about a new aesthetic neurotoxin that is being prescribed by the same doctors who invested in its launch. CBH Director of Research, Eric Campbell, PhD, says this "creates a classic conflict of interest.” Read full story>>